Clinical Trials Browser

Phase 2 × Neoplasms × Methylprednisolone Hemisuccinate × Clear all

NCT04810156 2022-12-14

I-HEP

Phase 2 Unknown

Hepatitis, Neoplasms, Chemical and Drug Induced Liver Injury